Today: 19 January 2026
Subscribe
Browse Category

Market News News 6 November 2025 - 12 November 2025

$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

DAX closes above 24,300 as Frankfurt rally resumes; RWE and Infineon lead — Market close, Nov 12, 2025

German blue‑chips rose 1.16% to 24,366.73 on Wednesday, keeping the DAX within sight of October’s record as European stocks touched fresh highs. Easing fears around the U.S. government shutdown and a clutch of upbeat corporate updates underpinned sentiment despite a softer ZEW reading. Investing Market snapshot (as of close): What moved the market European equities extended gains after signs Congress…
12 November 2025
··
Westpac’s $7 Billion Windfall Ignites ASX Rally Despite Mining Slump – Nov 3, 2025

Australian sharemarket today: S&P/ASX 200 closes at 8,799.5, down 0.22% — CBA extends slide, Life360 tumbles; energy and materials firm

Sydney — Wednesday, 12 November 2025 (AEDT) Australia’s sharemarket edged lower on Wednesday, with the benchmark S&P/ASX 200 finishing down 19.3 points (‑0.22%) at 8,799.5, as losses in the big banks and technology names offset strength across miners and defensives. The broader All Ordinaries also eased 0.21% to 9,079.4. Investing What moved the market Financials and tech dragged; defensives and…
12 November 2025
···
UAMY Stock Skyrockets on $245M Pentagon Deal – Bubble or Buy?

UAMY Stock Today (Nov. 11, 2025): United States Antimony Jumps on $106.7M Five‑Year Supply Deal as China Eases Antimony Export Ban; Q3 Results Due Tomorrow

Updated November 11, 2025 Key takeaways UAMY stock news today (Nov. 11, 2025) US Antimony signs $106.7M, five‑year supply deal. Before the bell, USAC announced a definitive five‑year agreement to supply antimony trioxide—used primarily as a flame‑retardant synergist for industrial fabrics—to a U.S.‑based manufacturer. The company notes the customer completed materials testing earlier in 2025, and the contract includes a five‑year renewal option beyond the initial term.…
11 November 2025
····
Gold Soars Past $4,000 for the First Time – Inside the Historic Rally and What’s Next

Gold Price Today, November 11, 2025: Bullion Near 3‑Week High Above $4,140 as Fed Cut Bets Grow and U.S. Shutdown Deal Advances

Spot gold hovers around $4,140/oz on Nov. 11, 2025—its highest in nearly three weeks—as traders price a December Fed cut and Washington edges toward ending the government shutdown. Here’s today’s price snapshot, drivers, technical levels, and what to watch next. At a glance (11/11/2025) Today’s price snapshot Gold extended Monday’s surge and is holding firm near $4,140/oz as of late…
11 November 2025
····
Rumble (RUM) soars on $767M Northern Data deal; Tether pledges up to $250M; Q3 revenue misses — Nov. 10, 2025

Rumble (RUM) soars on $767M Northern Data deal; Tether pledges up to $250M; Q3 revenue misses — Nov. 10, 2025

Rumble Inc. (NASDAQ: RUM) said today it will acquire German AI infrastructure firm Northern Data in an all‑stock transaction valued at roughly $767 million, unveiled two new commercial commitments from Tether worth up to $250 million, and released mixed Q3 2025 results. Shares initially jumped in early trading. What Rumble announced today Why it matters: The package signals Rumble’s pivot…
10 November 2025
····
USD/GBP Today, 10 November 2025: Pound Holds Near $1.3175 as Markets Eye UK Jobs, GDP and US CPI — Forecast & Key Levels

USD/GBP Today, 10 November 2025: Pound Holds Near $1.3175 as Markets Eye UK Jobs, GDP and US CPI — Forecast & Key Levels

Summary: Sterling is steady to start the week, with GBP/USD around $1.317–1.32 (≈ USD/GBP 0.759). Traders are focused on this week’s UK labour‑market and GDP releases and Thursday’s US CPI. Hopes that Washington’s government shutdown could soon end are nudging broader risk sentiment and the dollar index, but sterling is largely taking its cues from domestic data risk and the…
10 November 2025
··
Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?

Gold Price Today (10.11.2025): XAU/USD jumps above $4,070 as Fed cut bets rise; Senate advances plan to end U.S. shutdown

Updated Monday, 10 November 2025. Snapshot: Where gold stands right now Today’s key takeaways (10.11.2025) What moved the gold price today Weak U.S. macro signals are keeping the market focused on policy easing. A prolonged data blackout from the government shutdown has pushed traders toward private indicators, which point to labor‑market softening and plunging sentiment. That combination has nudged markets…
10 November 2025
····
Precious Metals Mania: Gold Smashes $4,000, Silver Soars Past $50 – What’s Driving the Frenzy?

Silver Price Today (10 Nov 2025): XAG/USD Jumps ~3% to Near $50 as Dollar Softens and Shutdown-Deal Hopes Lift Sentiment

Summary at a glance Live price snapshot (as of Monday, 10 Nov 2025) Note: Live prices change throughout the day. The levels above reflect the cited sources’ timestamps. What’s moving silver today 1) Softer dollar + hopes for a shutdown resolutionPrecious metals are drawing support from a slightly weaker U.S. dollar index and expectations that U.S. lawmakers are closer to…
10 November 2025
···
Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Qualys (QLYS) News Roundup for Nov. 7–8, 2025: Analyst Upgrade, EPS Estimate Lift, and Stock Holds Near $150 After Q3 Beat

Dateline: November 8, 2025 — Cybersecurity vendor Qualys, Inc. (NASDAQ: QLYS) stayed in the headlines heading into the weekend, with fresh analyst reactions following Tuesday’s earnings beat, a state pension fund disclosing a larger stake, and continued chatter around its agentic‑AI roadmap. Below is a concise, Google News–ready digest of everything new about Qualys published November 7–8, 2025. Key Points…
8 November 2025
···
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Comcast (CMCSA) Stock Today — Nov. 7, 2025: Sky–ITV Talks and a Potential WBD Bid Put M&A in Focus as Shares Hover Near $27

Published: November 7, 2025 Key takeaways Comcast stock price snapshot (Nov. 7, 2025) Comcast Corporation (NASDAQ: CMCSA) traded modestly lower today, holding near the $27 handle. As of 19:33 UTC (2:33 p.m. ET), the stock printed $27.28 after opening at $27.56, with volume around 20.9 million shares. Intraday, CMCSA ranged $27.02–$27.77, reflecting an active tape as investors reacted to fresh…
7 November 2025
····
Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining Company (NYSE: HL) is in focus today after reporting record third‑quarter results last night and hosting its earnings call this morning. The silver producer posted all‑time‑high quarterly revenue and net income, tightened 2025 production guidance, detailed permitting wins, and declared dividends on both common and preferred shares. Shares are trading sharply higher intraday amid the news. Q4Web Key…
6 November 2025
····
Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna (MRNA) Beats Q3 on Sales of New COVID Shot, Trims 2025 Outlook; Stock Whipsaws — Nov. 6, 2025

Moderna, Inc. (NASDAQ: MRNA) posted third‑quarter 2025 revenue of ~$1.02 billion and a GAAP loss of $0.51 per share, topping Wall Street estimates as sales of its updated COVID‑19 vaccine outperformed. The company narrowed its full‑year revenue range to $1.6–$2.0 billion, cut operating‑expense guidance, and raised its year‑end cash outlook. Shares popped in pre‑market trading before wobbling intraday. SEC What…
6 November 2025
···
1 … 56 57 58 59 60 … 64

Stock Market Today

  • Pfizer Q4 Preview: Non-Oncology Segment Sales Outlook and Market Impact
    January 19, 2026, 11:10 AM EST. Pfizer (PFE) is scheduled to report Q4 and full-year 2025 earnings on Feb. 3. While oncology sales account for over 28% of revenues, investor focus also shifts to non-oncology segments including Primary Care and Specialty Care. Key non-oncology products include Eliquis anticoagulant, Prevnar vaccines, COVID-19 vaccine Comirnaty, and newer drugs like RSV vaccine Abrysvo and migraine treatment Nurtec. Eliquis alliance revenues are expected to rise to $2.1 billion despite generic pressures. Prevnar vaccine sales likely declined in the U.S. but increased internationally, estimated at $1.64 billion. COVID-19 medication sales fell due to narrower vaccine recommendations and lower infections. In Specialty Care, Vyndaqel sales remain strong at an estimated $1.66 billion, while Xeljanz and Enbrel may have weakened. Pfizer's stock dropped 2.5% in past year, underperforming the industry, but trades at a forward price/earnings ratio of 8.58, suggesting valuation appeal.
Go toTop